{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:16:45Z","timestamp":1789755405902,"version":"4.0.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2003325"],"award-info":[{"award-number":["APP2003325"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1140619"],"award-info":[{"award-number":["APP1140619"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Department of Education and Training | Australian Research Council","doi-asserted-by":"publisher","award":["CE200100012"],"award-info":[{"award-number":["CE200100012"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The pathogen\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    can readily develop antibiotic resistance and evade the human immune system, which is associated with reduced levels of neutrophil recruitment. Here, we present a class of antibacterial peptides with potential to act both as antibiotics and as neutrophil chemoattractants. The compounds, which we term \u2018antibiotic-chemoattractants\u2019, consist of a formylated peptide (known to act as chemoattractant for neutrophil recruitment) that is covalently linked to the antibiotic vancomycin (known to bind to the bacterial cell wall). We use a combination of in vitro assays, cellular assays, infection-on-a-chip and in vivo mouse models to show that the compounds improve the recruitment, engulfment and killing of\n                    <jats:italic>S. aureus<\/jats:italic>\n                    by neutrophils. Furthermore, optimizing the formyl peptide sequence can enhance neutrophil activity through differential activation of formyl peptide receptors. Thus, we propose antibiotic-chemoattractants as an alternate approach for antibiotic development.\n                  <\/jats:p>","DOI":"10.1038\/s41467-021-26244-5","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T06:02:56Z","timestamp":1635141776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Antibiotic-chemoattractants enhance neutrophil clearance of Staphylococcus aureus"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4711-0501","authenticated-orcid":false,"given":"Jennifer A. E.","family":"Payne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Tailhades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4941-4346","authenticated-orcid":false,"given":"Felix","family":"Ellett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8611-2198","authenticated-orcid":false,"given":"Xenia","family":"Kostoulias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6278-7211","authenticated-orcid":false,"given":"Alex J.","family":"Fulcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1023-0443","authenticated-orcid":false,"given":"Stephanie","family":"Louch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9404-5645","authenticated-orcid":false,"given":"Amy","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severin A.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8738-1878","authenticated-orcid":false,"given":"Ralf B.","family":"Schittenhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0325-798X","authenticated-orcid":false,"given":"Graham J.","family":"Lieschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2169-2686","authenticated-orcid":false,"given":"Chengxue Helena","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7347-2082","authenticated-orcid":false,"given":"Daniel","family":"Irima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2296-2126","authenticated-orcid":false,"given":"Anton Y.","family":"Peleg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9739-6157","authenticated-orcid":false,"given":"Max J.","family":"Cryle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,25]]},"reference":[{"key":"26244_CR1","unstructured":"CDC. Antibiotic resistance threats in the United States. (Report, 2013)."},{"key":"26244_CR2","unstructured":"O\u2019Neill, J. The Review on antimicrobial resistance. (Report, 2016)."},{"key":"26244_CR3","doi-asserted-by":"crossref","unstructured":"Pfaller, M. A., Carvalhaes, C. G., Smith, C. J., Diekema, D. J. & Castanheira, M. Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (2012\u20132017). Diagn. Microbiol. Infect. Dis. 97, 115016 (2020).","DOI":"10.1016\/j.diagmicrobio.2020.115016"},{"key":"26244_CR4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fcimb.2017.00286","volume":"7","author":"FE Guerra","year":"2017","unstructured":"Guerra, F. E., Borgogna, T. R., Patel, D. M., Sward, E. W. & Voyich, J. M. Epic immune battles of history: neutrophils vs. Staphylococcus aureus. Front. Cell. Infect. Microbiol. 7, 286 (2017).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"26244_CR5","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1073\/pnas.1812066116","volume":"116","author":"JH Jiang","year":"2019","unstructured":"Jiang, J. H. et al. Antibiotic resistance and host immune evasion in Staphylococcus aureus mediated by a metabolic adaptation. Proc. Natl Acad. Sci. USA 116, 3722\u20133727 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"26244_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.meegid.2013.03.047","volume":"21","author":"BP Howden","year":"2014","unstructured":"Howden, B. P., Peleg, A. Y. & Stinear, T. P. The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA. Infect., Genet. Evolution 21, 575\u2013582 (2014).","journal-title":"Infect., Genet. Evolution"},{"key":"26244_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/antibiotics8020045","volume":"8","author":"B Ribeiro da Cunha","year":"2019","unstructured":"Ribeiro da Cunha, B., Fonseca, L. P. & Calado, C. R. C. Antibiotic discovery: Where have we come from, where do we go? Antibiotics (Basel) 8, 45 (2019).","journal-title":"Antibiotics (Basel)"},{"key":"26244_CR8","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00109-015-1280-4","volume":"93","author":"SA Kristian","year":"2015","unstructured":"Kristian, S. A. et al. Retargeting pre-existing human antibodies to a bacterial pathogen with an alpha-Gal conjugated aptamer. J. Mol. Med. 93, 619\u2013631 (2015).","journal-title":"J. Mol. Med."},{"key":"26244_CR9","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.chembiol.2018.05.019","volume":"25","author":"MS Feigman","year":"2018","unstructured":"Feigman, M. S. et al. Synthetic immunotherapeutics against Gram-negative pathogens. Cell Chem. Biol. 25, 1185\u20131194. e5 (2018).","journal-title":"Cell Chem. Biol."},{"key":"26244_CR10","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1039\/D0NA01018A","volume":"3","author":"JAE Payne","year":"2021","unstructured":"Payne, J. A. E. et al. Staphylococcus aureus entanglement in self-assembling \u03b2-peptide nanofibres decorated with vancomycin. Nanoscale Adv. 3, 2607\u20132616 (2021).","journal-title":"Nanoscale Adv."},{"key":"26244_CR11","doi-asserted-by":"crossref","unstructured":"Haney, E. F., Straus, S. K. & Hancock, R. E. W. Reassessing the host defense peptide landscape. Front. Chem. 7, 43 (2019).","DOI":"10.3389\/fchem.2019.00043"},{"key":"26244_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nri.2016.29","volume":"16","author":"REW Hancock","year":"2016","unstructured":"Hancock, R. E. W., Haney, E. F. & Gill, E. E. The immunology of host defence peptides: beyond antimicrobial activity. Nat. Rev. Immunol. 16, 321\u2013334 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"26244_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bcp.2016.04.014","volume":"114","author":"C Dahlgren","year":"2016","unstructured":"Dahlgren, C., Gabl, M., Holdfeldt, A., Winther, M. & Forsman, H. Basic characteristics of the neutrophil receptors that recognize formylated peptides, a danger-associated molecular pattern generated by bacteria and mitochondria. Biochemical Pharmacol. 114, 22\u201339 (2016).","journal-title":"Biochemical Pharmacol."},{"key":"26244_CR14","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1091\/mbc.E18-06-0358","volume":"30","author":"X Wen","year":"2019","unstructured":"Wen, X. et al. G-protein-coupled formyl peptide receptors play a dual role in neutrophil chemotaxis and bacterial phagocytosis. Mol. Biol. Cell 30, 346\u2013356 (2019).","journal-title":"Mol. Biol. Cell"},{"key":"26244_CR15","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1073\/pnas.72.3.1059","volume":"72","author":"E Schiffmann","year":"1975","unstructured":"Schiffmann, E., Corcoran, B. A. & Wahl, S. M. N-formylmethionyl peptides as chemoattractants for leucocytes. Proc. Natl Acad. Sci. USA 72, 1059\u20131062 (1975).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"26244_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1462-5822.2005.00610.x","volume":"8","author":"MC Durr","year":"2006","unstructured":"Durr, M. C. et al. Neutrophil chemotaxis by pathogen-associated molecular patterns-formylated peptides are crucial but not the sole neutrophil attractants produced by Staphylococcus aureus. Cell Microbiol. 8, 207\u2013217 (2006).","journal-title":"Cell Microbiol."},{"key":"26244_CR17","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1084\/jem.189.4.657","volume":"189","author":"JL Gao","year":"1999","unstructured":"Gao, J. L., Lee, E. J. & Murphy, P. M. Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor. J. Exp. Med. 189, 657\u2013662 (1999).","journal-title":"J. Exp. Med."},{"key":"26244_CR18","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1128\/AAC.47.8.2545-2550.2003","volume":"47","author":"H Fu","year":"2003","unstructured":"Fu, H., Dahlgren, C. & Bylund, J. Subinhibitory concentrations of the deformylase inhibitor actinonin increase bacterial release of neutrophil-activating peptides: a new approach to antimicrobial chemotherapy. Antimicrobial Agents Chemother. 47, 2545\u20132550 (2003).","journal-title":"Antimicrobial Agents Chemother."},{"key":"26244_CR19","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/ja.2014.111","volume":"67","author":"MS Butler","year":"2014","unstructured":"Butler, M. S., Hansford, K. A., Blaskovich, M. A. T., Halai, R. & Cooper, M. A. Glycopeptide antibiotics: Back to the future. J. Antibiotics 67, 631\u2013644 (2014).","journal-title":"J. Antibiotics"},{"key":"26244_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ja.2013.117","volume":"67","author":"G Yim","year":"2014","unstructured":"Yim, G., Thaker, M. N., Koteva, K. & Wright, G. Glycopeptide antibiotic biosynthesis. J. Antibiotics 67, 31\u201341 (2014).","journal-title":"J. Antibiotics"},{"key":"26244_CR21","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1128\/AAC.49.8.3122-3128.2005","volume":"49","author":"H Tsubery","year":"2005","unstructured":"Tsubery, H. et al. Neopeptide antibiotics that function as opsonins and membrane-permeabilizing agents for Gram-negative bacteria. Antimicrobial Agents Chemother. 49, 3122\u20133128 (2005).","journal-title":"Antimicrobial Agents Chemother."},{"key":"26244_CR22","doi-asserted-by":"crossref","unstructured":"Jones, C. N. et al. Bifunctional small molecules enhance neutrophil activities against Aspergillus fumigatus in vivo and in vitro. Front. Immunol. 10, 644 (2019).","DOI":"10.3389\/fimmu.2019.00644"},{"key":"26244_CR23","doi-asserted-by":"publisher","first-page":"18769","DOI":"10.1074\/jbc.REV119.006349","volume":"294","author":"E Marschall","year":"2019","unstructured":"Marschall, E., Cryle, M. J. & Tailhades, J. Biological, chemical, and biochemical strategies for modifying glycopeptide antibiotics. J. Biol. Chem. 294, 18769\u201318783 (2019).","journal-title":"J. Biol. Chem."},{"key":"26244_CR24","doi-asserted-by":"publisher","first-page":"11033","DOI":"10.1073\/pnas.0600829103","volume":"103","author":"K Tiyanont","year":"2006","unstructured":"Tiyanont, K. et al. Imaging peptidoglycan biosynthesis in Bacillus subtilis with fluorescent antibiotics. Proc. Natl Acad. Sci. 103, 11033\u201311038 (2006).","journal-title":"Proc. Natl Acad. Sci."},{"key":"26244_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3584","volume":"4","author":"M van Oosten","year":"2013","unstructured":"van Oosten, M. et al. Real-time in vivo imaging of invasive- and biomaterial-associated bacterial infections using fluorescently labelled vancomycin. Nat. Commun. 4, 2584 (2013).","journal-title":"Nat. Commun."},{"key":"26244_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78362-7","volume":"11","author":"HY Park","year":"2021","unstructured":"Park, H. Y. et al. Comparison of two fluorescent probes in preclinical non-invasive imaging and image-guided debridement surgery of Staphylococcal biofilm implant infections. Sci. Rep. 11, 1622 (2021).","journal-title":"Sci. Rep."},{"key":"26244_CR27","doi-asserted-by":"publisher","first-page":"10899","DOI":"10.1002\/anie.202003726","volume":"59","author":"J Tailhades","year":"2020","unstructured":"Tailhades, J. et al. A chemoenzymatic approach to the synthesis of glycopeptide antibiotic analogues. Angew. Chem. Int. Ed. 59, 10899\u201310903 (2020).","journal-title":"Angew. Chem. Int. Ed."},{"key":"26244_CR28","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/BF01967563","volume":"8","author":"PE Reynolds","year":"1989","unstructured":"Reynolds, P. E. Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 8, 943\u2013950 (1989).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"26244_CR29","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1128\/AAC.35.4.605","volume":"35","author":"R Nagarajan","year":"1991","unstructured":"Nagarajan, R. Antibacterial activities and modes of action of vancomycin and related glycopeptides. Antimicrobial Agents Chemother. 35, 605\u2013609 (1991).","journal-title":"Antimicrobial Agents Chemother."},{"key":"26244_CR30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1021\/ja00054a033","volume":"115","author":"U Gerhard","year":"1993","unstructured":"Gerhard, U., Mackay, J. P., Maplestone, R. A. & Williams, D. H. The role of the sugar and chlorine substituents in the dimerization of vancomycin antibiotics. Am. Chem. Soc. 115, 232\u2013237 (1993).","journal-title":"Am. Chem. Soc."},{"key":"26244_CR31","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1021\/jm500270w","volume":"57","author":"V Yarlagadda","year":"2014","unstructured":"Yarlagadda, V., Akkapeddi, P., Manjunath, G. B. & Haldar, J. Membrane active vancomycin analogs: A strategy to combat bacterial resistance. J. Medicinal Chem. 57, 4558\u20134568 (2014).","journal-title":"J. Medicinal Chem."},{"key":"26244_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02123-w","volume":"9","author":"MAT Blaskovich","year":"2018","unstructured":"Blaskovich, M. A. T. et al. Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria. Nat. Commun. 9, 22 (2018).","journal-title":"Nat. Commun."},{"key":"26244_CR33","doi-asserted-by":"publisher","first-page":"16140","DOI":"10.1021\/jacs.8b08711","volume":"140","author":"A Antonoplis","year":"2018","unstructured":"Antonoplis, A. et al. A dual-function antibiotic-transporter conjugate exhibits superior activity in sterilizing MRSA biofilms and killing persister cells. J. Am. Chem. Soc. 140, 16140\u201316151 (2018).","journal-title":"J. Am. Chem. Soc."},{"key":"26244_CR34","doi-asserted-by":"publisher","first-page":"8823","DOI":"10.1002\/anie.202002727","volume":"59","author":"F Umst\u00e4tter","year":"2020","unstructured":"Umst\u00e4tter, F. et al. Vancomycin resistance is overcome by conjugation of polycationic peptides. Angew. Chem. Int. Ed. 59, 8823\u20138827 (2020).","journal-title":"Angew. Chem. Int. Ed."},{"key":"26244_CR35","doi-asserted-by":"crossref","first-page":"E5052","DOI":"10.1073\/pnas.1704125114","volume":"114","author":"A Okano","year":"2017","unstructured":"Okano, A., Isley, N. A. & Boger, D. L. Peripheral modifications of [\u03a8[CH2NH]Tpg4]vancomycin with added synergistic mechanisms of action provide durable and potent antibiotics. Proc. Natl Acad. Sci. 114, E5052\u2013E5061 (2017).","journal-title":"Proc. Natl Acad. Sci."},{"key":"26244_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15009-1","volume":"11","author":"T Chen","year":"2020","unstructured":"Chen, T. et al. Structural basis of ligand binding modes at the human formyl peptide receptor 2. Nat. Commun. 11, 1208 (2020).","journal-title":"Nat. Commun."},{"key":"26244_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14728-9","volume":"11","author":"Y Zhuang","year":"2020","unstructured":"Zhuang, Y. et al. Structure of formylpeptide receptor 2-Gi complex reveals insights into ligand recognition and signaling. Nat. Commun. 11, 885 (2020).","journal-title":"Nat. Commun."},{"key":"26244_CR38","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1021\/bi00552a019","volume":"19","author":"RJ Freer","year":"1980","unstructured":"Freer, R. J. et al. Further studies on the structural requirements for synthetic peptide chemoattractants. Biochemistry 19, 2404\u20132410 (1980).","journal-title":"Biochemistry"},{"key":"26244_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0167-4838(99)00081-3","volume":"1432","author":"A Dalpiaz","year":"1999","unstructured":"Dalpiaz, A. et al. Phe-d-Leu-Phe-d-Leu-Phe derivatives as formyl peptide receptor antagonists in human neutrophils: cellular and conformational aspects. BBA - Protein Struct. Mol. Enzymol. 1432, 27\u201339 (1999).","journal-title":"BBA - Protein Struct. Mol. Enzymol."},{"key":"26244_CR40","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0014-2999(00)00908-0","volume":"411","author":"A Dalpiaz","year":"2001","unstructured":"Dalpiaz, A. et al. Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors. Eur. J. Pharmacol. 411, 327\u2013333 (2001).","journal-title":"Eur. J. Pharmacol."},{"key":"26244_CR41","first-page":"668","volume":"221","author":"E Wei\u00df","year":"2019","unstructured":"Wei\u00df, E., Schlatterer, K., Beck, C., Peschel, A. & Kretschmer, D. Formyl-peptide receptor activation enhances phagocytosis of community-acquired methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 221, 668\u2013678 (2019).","journal-title":"J. Infect. Dis."},{"key":"26244_CR42","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/BF01965515","volume":"17","author":"N Berend","year":"1986","unstructured":"Berend, N., Armour, C. L. & Black, J. L. Formyl-methionyl-leucyl-phenylalanine causes bronchoconstriction in rabbits. Agents Actions 17, 466\u2013471 (1986).","journal-title":"Agents Actions"},{"key":"26244_CR43","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1136\/thx.47.4.284","volume":"47","author":"MJ Peters","year":"1992","unstructured":"Peters, M. J., Breslin, A. B., Kemp, A. S., Chu, J. & Berend, N. Haematological effects of inhalation of N-formyl-methionyl-leucyl-phenylalanine in man. Thorax 47, 284\u2013287 (1992).","journal-title":"Thorax"},{"key":"26244_CR44","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.4049\/jimmunol.124.4.2020","volume":"124","author":"RA Clark","year":"1980","unstructured":"Clark, R. A., Szot, S., Venkatasubramanian, K. & Schiffmann, E. Chemotactic factor inactivation by myeloperoxidase-mediated oxidation of methionine. J. Immunol. 124, 2020\u20132026 (1980).","journal-title":"J. Immunol."},{"key":"26244_CR45","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1039\/C8LC01263F","volume":"19","author":"F Ellett","year":"2019","unstructured":"Ellett, F. et al. Microfluidic arenas for war games between neutrophils and microbes. Lab on a Chip. 19, 1205\u20131216 (2019).","journal-title":"Lab on a Chip"},{"key":"26244_CR46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1124\/pr.109.001578","volume":"61","author":"RD Ye","year":"2009","unstructured":"Ye, R. D. et al. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol. Rev. 61, 119\u2013161 (2009).","journal-title":"Pharmacol. Rev."},{"key":"26244_CR47","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1189\/jlb.2A0514-275R","volume":"97","author":"D Kretschmer","year":"2015","unstructured":"Kretschmer, D., Rautenberg, M., Linke, D. & Peschel, A. Peptide length and folding state govern the capacity of staphylococcal \u03b2-type phenol-soluble modulins to activate human formyl-peptide receptors 1 or 2. J. Leukoc. Biol. 97, 689\u2013697 (2015).","journal-title":"J. Leukoc. Biol."},{"key":"26244_CR48","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.bbamcr.2014.10.021","volume":"1853","author":"H Forsman","year":"2015","unstructured":"Forsman, H. et al. Structural changes of the ligand and of the receptor alters the receptor preference for neutrophil activating peptides starting with a formylmethionyl group. Biochimica et. Biophysica Acta 1853, 192\u2013200 (2015).","journal-title":"Biochimica et. Biophysica Acta"},{"key":"26244_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14232","volume":"8","author":"CX Qin","year":"2017","unstructured":"Qin, C. X. et al. Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice. Nat. Commun. 8, 14232 (2017).","journal-title":"Nat. Commun."},{"key":"26244_CR50","doi-asserted-by":"publisher","first-page":"5242","DOI":"10.1021\/acs.jmedchem.8b01912","volume":"62","author":"GS Deora","year":"2019","unstructured":"Deora, G. S. et al. Substituted pyridazin-3(2H)-ones as highly potent and biased formyl peptide receptor agonists. J. Medicinal Chem. 62, 5242\u20135248 (2019).","journal-title":"J. Medicinal Chem."},{"key":"26244_CR51","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/B978-0-12-394440-5.00014-0","volume":"118","author":"D Jiang","year":"2013","unstructured":"Jiang, D., Xie, T., Liang, J. & Noble, P. W. \u03b2-Arrestins in the immune system. Prog. Mol. Biol. Transl. Sci. 118, 359\u2013393 (2013).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"26244_CR52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1021\/acsptsci.9b00097","volume":"3","author":"T Fu","year":"2020","unstructured":"Fu, T. et al. Therapeutic potential of lipoxin A4 in chronic inflammation: focus on cardiometabolic disease. ACS Pharmacol. Transl. Sci. 3, 43\u201355 (2020).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"26244_CR53","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fimmu.2017.00257","volume":"8","author":"H Bj\u00f6rnsdottir","year":"2017","unstructured":"Bj\u00f6rnsdottir, H. et al. Phenol-soluble modulin \u03b1 peptide toxins from aggressive Staphylococcus aureus induce rapid formation of neutrophil extracellular traps through a reactive oxygen species-independent pathway. Front. Immunol. 8, 257 (2017).","journal-title":"Front. Immunol."},{"key":"26244_CR54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pharmthera.2014.11.012","volume":"148","author":"C Qin","year":"2015","unstructured":"Qin, C. et al. Cardioprotective potential of annexin-A1 mimetics in myocardial infarction. Pharmacol. Therapeutics 148, 47\u201365 (2015).","journal-title":"Pharmacol. Therapeutics"},{"key":"26244_CR55","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.bbadis.2007.06.001","volume":"1772","author":"JS Mills","year":"2007","unstructured":"Mills, J. S. Differential activation of polymorphisms of the formyl peptide receptor by formyl peptides. Biochimica et. Biophysica Acta 1772, 1085\u20131092 (2007).","journal-title":"Biochimica et. Biophysica Acta"},{"key":"26244_CR56","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00251-008-0277-3","volume":"60","author":"JM Gripentrog","year":"2008","unstructured":"Gripentrog, J. M., Mills, J. S., Saari, G. J. & Miettinen, H. M. Variable responses of formyl peptide receptor haplotypes toward bacterial peptides. Immunogenetics 60, 83\u201393 (2008).","journal-title":"Immunogenetics"},{"key":"26244_CR57","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1042\/BJ20121839","volume":"451","author":"C Zhou","year":"2013","unstructured":"Zhou, C. et al. V101L of human formyl peptide receptor 1 (FPR1) increases receptor affinity and augments the antagonism mediated by cyclosporins. Biochemical J. 451, 245\u2013255 (2013).","journal-title":"Biochemical J."},{"key":"26244_CR58","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.bbrc.2010.12.136","volume":"405","author":"T Otani","year":"2011","unstructured":"Otani, T. et al. Polymorphisms of the formylpeptide receptor gene (FPR1) and susceptibility to stomach cancer in 1531 consecutive autopsy cases. Biochemical Biophysical Res. Commun. 405, 356\u2013361 (2011).","journal-title":"Biochemical Biophysical Res. Commun."},{"key":"26244_CR59","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1902\/jop.2009.090103","volume":"80","author":"P Maney","year":"2009","unstructured":"Maney, P. & Walters, J. D. Formylpeptide receptor single nucleotide polymorphism 348T>C and its relationship to polymorphonuclear leukocyte chemotaxis in aggressive periodontitis. J. Periodontol. 80, 1498\u20131505 (2009).","journal-title":"J. Periodontol."},{"key":"26244_CR60","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s004410051042","volume":"292","author":"EL Becker","year":"1998","unstructured":"Becker, E. L. et al. Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues, and cells. Cell Tissue Res. 292, 129\u2013135 (1998).","journal-title":"Cell Tissue Res."},{"key":"26244_CR61","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.4049\/jimmunol.181.2.1429","volume":"181","author":"EL Southgate","year":"2008","unstructured":"Southgate, E. L. et al. Identification of formyl peptides from Listeria monocytogenes and Staphylococcus aureus as potent chemoattractants for mouse neutrophils. J. Immunol. 181, 1429\u20131437 (2008).","journal-title":"J. Immunol."},{"key":"26244_CR62","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/bip.21288","volume":"94","author":"L Ronga","year":"2010","unstructured":"Ronga, L. et al. Insertion of multiple \u03b1-amino \u03b3-lactam (Agl) residues into a peptide sequence by solid-phase synthesis on synphase lanterns. Pept. Sci. 94, 183\u2013191 (2010).","journal-title":"Pept. Sci."},{"key":"26244_CR63","first-page":"1","volume":"5","author":"W Sun","year":"2016","unstructured":"Sun, W. et al. Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria. Emerg. Microbes Infect. 5, 1\u201311 (2016).","journal-title":"Emerg. Microbes Infect."},{"key":"26244_CR64","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"26244_CR65","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ymeth.2016.09.016","volume":"115","author":"J-Y Tinevez","year":"2017","unstructured":"Tinevez, J.-Y. et al. TrackMate: an open and extensible platform for single-particle tracking. Methods 115, 80\u201390 (2017).","journal-title":"Methods"},{"key":"26244_CR66","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1074\/jbc.M113.509216","volume":"289","author":"H-Q He","year":"2014","unstructured":"He, H.-Q., Troksa, E. L., Caltabiano, G., Pardo, L. & Ye, R. D. Structural determinants for the interaction of formyl peptide receptor 2 with peptide ligands. J. Biol. Chem. 289, 2295\u20132306 (2014).","journal-title":"J. Biol. Chem."},{"key":"26244_CR67","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1021\/jm501051x","volume":"58","author":"O Corminboeuf","year":"2015","unstructured":"Corminboeuf, O. & Leroy, X. FPR2\/ALXR agonists and the resolution of inflammation. J. Medicinal Chem. 58, 537\u2013559 (2015).","journal-title":"J. Medicinal Chem."},{"key":"26244_CR68","doi-asserted-by":"publisher","first-page":"15034","DOI":"10.1038\/nmicrobiol.2015.34","volume":"1","author":"M Speir","year":"2016","unstructured":"Speir, M. et al. Eliminating Legionella by inhibiting BCL-XL to induce macrophage apoptosis. Nat. Microbiol. 1, 15034 (2016).","journal-title":"Nat. Microbiol."},{"key":"26244_CR69","doi-asserted-by":"publisher","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2019","unstructured":"Perez-Riverol, Y. et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res 47, D442\u2013D450 (2019).","journal-title":"Nucleic Acids Res"},{"key":"26244_CR70","doi-asserted-by":"crossref","unstructured":"Medical, B. Medical gallery of Blausen Medical 2014. WikiJ. Med. 1, 10 (2014).","DOI":"10.15347\/wjm\/2014.010"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26244-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26244-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26244-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T12:08:55Z","timestamp":1673611735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26244-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,25]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["26244"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-26244-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.741044581.793590083","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,25]]},"assertion":[{"value":"20 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.Y.P., J.A.E.P., J.T., and M.J.C. have filed for patent protection (PCT\/AU2021\/050306) of the antibiotic-chemoattractant compounds. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6157"}}